Hailin Wang

Title: Hailin Wang: Innovator in RNA Virus Research

Introduction

Hailin Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of RNA virus research, particularly through his innovative patent that addresses critical aspects of viral detection and treatment. His work has implications for vaccine design and disease management.

Latest Patents

Hailin Wang holds a patent titled "Target sequence of RNA virus and use thereof." This invention provides a target sequence of an RNA virus, which is a nucleic acid sequence fragment containing 20-40 bases with at least 95% similarity to the genome sequence of humans or related species, such as livestock and poultry. The patent outlines a primer composition for constructing the target sequence, biomaterials like antisense RNA, and various applications, including vaccine design. The invention proposes that the target fragment is an important pathogenic substance of the RNA virus, with significant value for detection, diagnosis, drug screening, and treatment of RNA virus-related diseases.

Career Highlights

Hailin Wang has worked with notable organizations, including the Shanghai Public Health Clinical Center and Shanghai Yizhe Biotechnology Co., Ltd. His experience in these institutions has allowed him to collaborate on various research projects and contribute to advancements in biotechnology and public health.

Collaborations

Hailin Wang has collaborated with esteemed colleagues, including Wenqiang Yu and Zhenyan Li. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field of RNA viruses.

Conclusion

Hailin Wang's contributions to RNA virus research through his patent and collaborations highlight his role as an influential inventor in the biotechnology sector. His work continues to pave the way for advancements in viral detection and treatment strategies.